Abstract
The effect of acute and chronic cadmium administration on hepatic drug metabolism was investigated in the male rat. 3 days after the acute administration of cadmium by either the intraperitoneal (0.84 mg Cd/kg) or the oral (> 80 mg Cd/kg) route, there was a significant potentiation in duration of hexobarbital hypnosis and inhibition of hepatic microsomal metabolism of hexobarbital and aniline. Administration of cadmium in the drinking water at levels of 100 or 200 ppm Cd for periods of 2–12 weeks or at levels of 5 or 20 ppm Cd for 50 weeks did not produce alterations in either drug response or hepatic drug metabolism. Significant levels of metallothionein, a cadmium binding protein, found in the liver of the rats receiving cadmium chronically may offer an explanation for the observed differences in drug metabolism between the acute and chronic administration of cadmium. In additional studies, pretreatment of the rats with subthreshold doses of cadmium (0.21 or 0.42 mg Cd/kg) intraperitoneally produced a tolerance to the alterations in drug metabolism induced by the previous cadmium dose (0.84 mg Cd/kg, i.p.). However, chronic cadmium treatment (5 or 20 ppm Cd for 50 weeks) did not impart any such tolerance to subsequently administered Cd (0.84 mg/kg) by the intraperitoneal route. The hepatic levels of metallothionein induced by the chronic cadmium treatment were only 30–60% of those induced by the subthreshold cadmium and thus may not have bound enough of the large challenge cadmium dose to produce the tolerance phenomenon.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anderson, V. L., McLean, R. A.: Design of experiments: a realistic approach. New York: Marcel Dekker 1974
Becking, G. C.: Trace elements and drug metabolism. Med. Clin. N. Amer. 60, 813–830 (1976)
Brodie, B., Burns, J., Lief, P., Bernstein, E., Papper, E.: The fate of pentobarbital in man and dog and a method for its estimation in biological material. J. Pharmacol. exp. Ther. 109, 26–34 (1953)
Cotzias, G. C., Borg, D. C., Selleck, B.: Virtual absence of turnover in cadmium metabolism: 109Cd studies in the mouse. Amer. J. Physiol. 201, 927–930 (1961)
Decker, C. F., Byerrum, R. U., Hoppert, C. A.: A study on the distribution and retention of 115Cd in the albino rat. Arch. Biochem. Biophys. 66, 140–145 (1957)
Flick, D. F., Kraybill, H. F., Dimitroff, J. M.: Toxic effects of cadmium: A review. Environ. Res. 4, 71–85 (1971)
Friberg, L., Piscator, M., Nordberg, G. F., Kjellstrom, T.: Cadmium in the environment, 2nd ed. Cleveland: CRC Press 1974
Ghafghazi, T., Mennear, J. H.: Effects of acute and subacute cadmium administration on carbohydrate metabolism in mice. Toxicol. appl. Pharmacol. 26, 231–240 (1973)
Hadley, W. M., Miya, T. S., Bousquet, W. F.: Cadmium inhibition of hepatic drug metabolism in the rat. Toxicol. appl. Pharmacol. 28, 284–291 (1974)
Imai, Y., Ito, A., Sato, R.: Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. J. Biochem. (Tokyo) 60, 417–428 (1966)
Johnston, R. E., Miya, T. S., Schnell, R. C.: Cadmium potentiation of drug response — role of the liver. Biochem. Pharmacol. 24, 877–881 (1975)
Kotsonis, F. N., Klaassen, C. D.: Toxicity and distribution of cadmium administered to rats at sublethal doses. Toxicol. appl. Pharmacol. 41, 667–680 (1977)
Leber, A. P., Miya, T. S.: A mechanism for cadmium and zinc induced tolerance to cadmium toxicity: involvement of metallothionein. Toxicol. appl. Pharmacol. 37, 403–414 (1976)
Louria, D. B., Joselow, M. M., Brosder, A. A.: The human toxicity of certain trace elements. Ann. intern. Med. 76, 307–319 (1972)
Merali, Z., Kacew, S., Singhal, R. L.: Response of hepatic carbohydrate and cyclic AMP metabolism to cadmium treatment in rats. Canad. J. Physiol. Pharmacol. 53, 174–184 (1975)
Moore, W., Stara, J. F., Crocker, W. C.: Gastrointestinal absorption of different compounds of 115Cd and the effect of different concentrations in the rat. Environ. Res. 6, 159–164 (1973)
Nordberg, G. F.: Effects of acute and chronic cadmium exposure on the testicles of mice. Environ. Physiol. Biochem. 1, 171–187 (1971)
Pence, D. H., Miya, T. S., Schnell, R. C.: Cadmium alteration of hexobarbital action: sex-related differences in the rat. Toxicol. appl. Pharmacol. 39, 89–96 (1977)
Probst, G. S., Bousquet, W. F., Miya, T. S.: Kinetics of cadmium-induced hepatic and renal metallothionein synthesis in the mouse. Toxicol. appl. Pharmacol. 39, 51–60 (1977a)
Probst, G. S., Bousquet, W. F., Miya, T. S.: Correlation of hepatic metallothionein concentrations with acute cadmium toxicity in the mouse. Toxicol. appl. Pharmacol. 39, 61–69 (1977b)
Roberts, S. A., Miya, T. S., Schnell, R. C.: Tolerance development to cadmium-induced alteration of drug action. Res. Commun. Chem. Pathol. Pharmacol. 14, 197–200 (1976)
Schnell, R. C., Prosser, T. D., Miya, T. S.: Cadmium-induced potentiation of hexobarbital sleep time in rats. Experientia (Basel) 30, 528–529 (1974)
Squibb, K. S., Cousins, R. J.: Control of cadmium binding protein synthesis in rat liver. Environ. Physiol. Biochem. 4, 24–30 (1974)
Squibb, K. S., Cousins, R. J., Silbon, B. L., Levin, S.: Liver and intestinal metallothionein: function in acute cadmium toxicity. Exp. molec. Path. 25, 163–171 (1976)
Wagstaff, D. D.: Stimulation of liver detoxication enzymes by Dietary cadmium acetate. Bull. Environm. Contamin. Toxicol. 10, 328–332 (1973)
Webb, M.: Binding of cadmium ions by rat liver and kidney. Biochem. Pharmacol. 21, 2751–2765 (1972)
Yau, E. T., Mennear, J. H.: Pancreatic metallothionein: protection against cadmium-induced inhibition of insulin secretory activity. Toxicol. appl. Pharmacol. 39, 515–520 (1977)
Yoshida, T., Ito, Y., Suzuki, Y., Uchiyama, M.: Inhibition of hepatic drug metabolizing enzyme by cadmium in mice. Bull. Environm. Contamin. Toxicol. 15, 402–405 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schnel, R.C., Yuhas, E.M., Pence, D.H. et al. Effect of acute and chronic cadmium treatment on hepatic drug metabolism in male rats. Arch. Toxicol. 40, 269–277 (1978). https://doi.org/10.1007/BF00310332
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00310332